Literature DB >> 15204037

Interactions of "ultra-low" doses of naltrexone and morphine in mature and young male and female rats.

Scott R Hamann1, Hammad Malik, Jewell W Sloan, Elzbieta P Wala.   

Abstract

Sex and age influence morphine analgesia in humans and animals. Mature rats show greater morphine analgesia in males than in females. Ultra-low doses of naltrexone enhance morphine analgesia. In mature rats (18-22 weeks), naltrexone (0.002-2.0 mg/kg)-morphine (2 mg/kg) cotreatment enhanced morphine analgesia in females, an effect inversely related to naltrexone dose. Conversely, in mature male rats, naltrexone tended to decrease morphine analgesia with increasing dose. In young rats (8-10 weeks), morphine analgesia was unrelated to sex and in both sexes the naltrexone-morphine interaction was negligible. These data show that dose, age, and sex alter the naltrexone-morphine interaction in rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15204037     DOI: 10.1080/10606820490464334

Source DB:  PubMed          Journal:  Receptors Channels        ISSN: 1060-6823


  4 in total

1.  Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.

Authors:  N S Abul-Husn; M Sutak; B Milne; K Jhamandas
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

2.  Individualized pain medicine.

Authors:  Hyungsuk Kim; Raymond A Dionne
Journal:  Drug Discov Today Ther Strateg       Date:  2009

3.  Differences in morphine-induced antinociception in male and female offspring born of morphine exposed mothers.

Authors:  Masoomeh Biglarnia; Manizheh Karami; Zahra Khodabakhshi Hafshejani
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

4.  Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence.

Authors:  Theresa Alexandra Mattioli; Heather Leduc-Pessah; Graham Skelhorne-Gross; Chris J B Nicol; Brian Milne; Tuan Trang; Catherine M Cahill
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.